Vocera to Present at 28th Annual Piper Jaffray Healthcare Conference

SAN JOSE, Calif., Nov. 15, 2016 (GLOBE NEWSWIRE) -- Vocera Communications, Inc. (NYSE: VCRA), the leading healthcare communications company, today announced that company executives will present to institutional investors at the 28th Annual Piper Jaffray Healthcare Conference on Tuesday, Nov. 29 at 12:30 p.m. ET in New York.  The discussion will be available as a webcast, both live and archived, through the Vocera website at investors.vocera.com. The replay will be available for 90 days following the live broadcast.

Important Notice Regarding Forward-Looking StatementsComments or responses to questions at the conference may contain forward-looking information, including statements regarding projected operating results and anticipated market opportunities for Vocera. This forward-looking information is subject to risks and uncertainties described in Vocera's filings with the Securities and Exchange Commission, and actual results or events may differ materially.

About Vocera Vocera Communications, Inc. offers the most robust clinical communications system in healthcare. Vocera delivers secure, integrated and intelligent communication solutions that enable care teams to collaborate more efficiently by delivering the right information, to the right person, on the right device, in the right location, at the right time. Vocera solutions provide hands-free voice communication, secure text messaging, patient engagement tools, and integrated clinical workflow with EHRs, nurse call systems and physiologic monitors. These solutions help improve operational efficiency, quality of care, safety and satisfaction across the continuum of care. In addition to technology solutions, Vocera drives thought leadership and new standards in care to elevate patient, family, nurse and physician experiences via the company's research collaborative, the Experience Innovation Network. Vocera is led by President and CEO Brent Lang and is headquartered in San Jose, California, with offices in San Francisco, Tennessee, Indiana, Canada, India, United Arab Emirates and the United Kingdom. Robert J. Zollars is the Chairman of the Board. For more information, visit www.vocera.com and @VoceraComm on Twitter.

The Vocera logo is a trademark of Vocera Communications, Inc. Vocera® is a trademark of Vocera Communications, Inc. registered in the United States and other jurisdictions. All other trademarks appearing in this release are the property of their respective owners.

CONTACTS:

Investors and Analysts:
Sue Dooley
Vocera
408.882.5971
[email protected]

Media:
Tara Stultz
Amendola Communications
440.225.9595
[email protected]

You May Also Be Interested In

• FDA grants fast track status to CytomX drug for colorectal cancer
• Kazia Therapeutics launches public offering of ADS and warrants
• Outlook Therapeutics names Kevin Lundquist as CFO ahead of U.S. launch